Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Anbio Biotechnology (NNNN) had Cash Flow from Investing Activities of $-4.20M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$30.24M |
|
-- |
|
-- |
|
$30.24M |
|
$0.09M |
|
-- |
|
-- |
|
$0.09M |
|
$30.16M |
|
$30.16M |
|
$30.16M |
|
-- |
|
| Cash Flow Statement Financials | |
$-6.74M |
|
|
Cash Flow from Investing Activities |
$-4.20M |
$6.95M |
|
$11.76M |
|
$7.77M |
|
$-3.99M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|